Previous Article | Next Article 
Infection and Immunity, May 2003, p. 2881-2884, Vol. 71, No. 5
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.5.2881-2884.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Histidine and Aspartic Acid Residues Important for Immunoglobulin G Endopeptidase Activity of the Group A Streptococcus Opsonophagocytosis-Inhibiting Mac Protein
Benfang Lei, Mengyao Liu, Elishia G. Meyers, Heather M. Manning, Michael J. Nagiec, and James M. Musser*
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840
Received 13 November 2002/
Returned for modification 16 January 2003/
Accepted 7 February 2003

ABSTRACT
The secreted Mac protein made by serotype M1 group A
Streptococcus (GAS) (designated Mac
5005) inhibits opsonophagocytosis and killing
of GAS by human polymorphonuclear neutrophils. This protein
also has cysteine endopeptidase activity against human immunoglobulin
G (IgG). Site-directed mutagenesis was used to identify histidine
and aspartic acid residues important for Mac IgG endopeptidase
activity. Replacement of His262 with Ala abolished Mac5005 IgG
endopeptidase activity. Asp284Ala and Asp286Ala mutant proteins
had compromised enzymatic activity, whereas 21 other Asp-to-Ala
mutant proteins cleaved human IgG at the apparent wild-type
level. The results suggest that His262 is an active-site residue
and that Asp284 and Asp286 are important for the enzymatic activity
or structure of Mac protein. These Mac mutants provide new information
about structure-activity relationships in this protein and will
assist study of the mechanism of inhibition of opsonophagocytosis
and killing of GAS by Mac.

TEXT
The human pathogen group A
Streptococcus (GAS) has evolved multiple
mechanisms to evade host defenses, such as phagocytosis and
killing by polymorphonuclear leukocytes (PMNs) and complement-mediated
cell lysis (
2,
3). Recently, we identified a secreted protein
(designated Mac) with homology to the

-subunit of human Mac-1
protein by proteome analysis of culture supernatant proteins
made by serotype M1 and M3 GAS strains (
5). Analysis of sera
obtained from human patients with GAS infections and mice with
soft tissue infections revealed that Mac is made in the course
of host-pathogen interactions (
5,
6). We reported that Mac binds
to human PMNs, diminishes IgG binding to CD16, and inhibits
opsonophagocytosis and killing of GAS by human PMNs (
6).
Subsequently, it was found that Mac has proteinase activity against human IgG (10), although it does not have significant homology with other known proteases. DNA sequence analysis of the mac gene in natural populations of GAS identified two major allele families of mac that differ from one another largely due to substantial divergence in the middle one-third of the mac gene and Mac protein (Fig. 1) (7). We have also shown that two Mac variants (Mac5005 made by serotype M1 strain MGAS5005 and Mac8345 made by serotype M28 strain MGAS8345) representing two Mac variant complexes have IgG endopeptidase activity (7). Replacement of Cys94 with Ala destroyed the IgG endopeptidase activity of Mac5005 (7), consistent with the idea that this amino acid is a catalytically active residue, an idea put forth on the basis of biochemical data (10). A thiolate-imidazolium ion pair formed from the side chains of active-site residues Cys and His is used for catalysis in many cysteine proteases (8). In addition, an Asp residue is sometimes involved in enzymatic activity in cysteine proteases (1). The goal of the present study was to gain additional insight into structure-activity relationships in Mac protein by identifying histidine and aspartic acid residues involved in Mac IgG endopeptidase activity. We also sought to generate mutant proteins that would be useful for subsequent studies on the mechanism of inhibition of opsonophagocytosis and killing of GAS by Mac.
Amino acid sequence alignment found that 6 His and 16 Asp residues
are conserved among protein Mac
5005, Mac
8345, and a Mac homologue
of
Streptococcus equi (Fig.
1). These conserved His and Asp
residues of the Mac
5005 protein were each replaced with alanine
using a QuickChange XL Site-Directed Mutagenesis kit (Stratagene,
La Jolla, Calif.), pSP22 containing
mac5005 (
5), and oligonucleotide
primers (Table
1). The mutant genes were sequenced to confirm
the presence of the desired nucleotide substitution and rule
out spurious mutations. Each recombinant Mac mutant was expressed
in
Escherichia coli BL21 (Novagen, Madison, Wis.) containing
a plasmid with the corresponding
mac mutant gene. To screen
for IgG endopeptidase activity, recombinant
E. coli BL21 was
grown at 37°C for 10 h in 3 ml of Luria-Bertani broth supplemented
with 100 mg of ampicillin per liter. Cells were pelleted by
centrifugation, suspended in 0.3 ml of 10 mM Tris-HCl buffer
(pH 8.0), and sonicated for 10 s. The lysate was centrifuged
to remove cell debris, and the supernatant was assayed for enzymatic
activity.
The control
E. coli lysate did not cleave human IgG heavy chain
(Fig.
2A). The Mac
5005 His262Ala mutant did not cleave IgG,
whereas the other five Mac
5005 His-to-Ala mutant proteins had
apparent wild-type proteolytic activity (Fig.
2A), consistent
with the idea that His262 is critical for IgG endopeptidase
activity. Also consistent with this notion, replacement of the
corresponding His residue of Mac
8345 (His264) with Ala resulted
in a mutant protein that did not cleave IgG (data not shown).
These results suggest that His262 of Mac
5005 and His264 of Mac
8345 play a catalytic role in the enzymatic activity.
Replacement of 14 of the 16 conserved Asp residues in Mac
5005 protein with Ala did not demonstrably alter IgG endopeptidase
activity (Fig.
2B). However, the Asp284Ala and Asp286Ala amino
acid replacements resulted in substantially decreased enzymatic
activity (Fig.
2B). The level of enzymatic activity of the Asp284Ala/Asp286Ala
double-mutant protein was similar to that of the Asp284Ala mutant
protein (Fig.
2B), ruling out the possibility that Asp284 of
Asp286Ala mutant protein and Asp286 of Asp284Ala mutant protein
were responsible for the residual activities of the mutants.
Inasmuch as Mac
5005 and Mac
8345 have more than 50% mismatched
amino acid residues in the central one-third of the proteins,
it is possible that nonconserved Asp residues may be important
for enzymatic activity. To rule out this possibility, seven
nonconserved Asp residues of Mac
5005 were replaced with Ala.
All of these mutants cleaved human IgG at the apparent wild-type
level (Fig.
2C).
To compare enzymatic activity more accurately, the Mac5005 His262Ala, Asp284Ala, and Asp286Ala mutant proteins were purified to apparent homogeneity (Fig. 3A) by the procedures previously described for the wild-type Mac5005 protein (7). All of the results generated with crude recombinant enzyme present in the E. coli lysates were confirmed with the purified mutant proteins (Fig. 3B).
The Mac
5005 Asp284Ala mutant protein was present in the
E. coli lysate at a level notably lower than those of the wild-type
and most of the other mutant proteins (Fig.
2B), suggesting
that this mutant protein might form an insoluble aggregate (inclusion
body). To examine this issue further, the levels of the Asp284Ala
mutant protein present in the whole cell, soluble fraction,
and insoluble fraction of the recombinant
E. coli cells were
compared with those of wild-type and Cys94Ala, His262Ala, and
Asp286Ala mutant Mac
5005 proteins. The amount of Mac
5005 Asp284Ala
mutant protein present as an inclusion body exceeded those of
the other recombinant Mac proteins (Fig.
4), suggesting that
the Asp284Ala amino acid replacement changes the structure of
Mac. In contrast, the Asp286Ala mutant protein did not form
an inclusion body (Fig.
4), suggesting that this amino acid
replacement did not alter the structure of Mac. Although the
decrease in the enzymatic activity caused by the Asp286Ala mutation
suggests that Asp286 participates in catalysis, an alternative
explanation is that this aspartic acid residue simply enhances
proteolytic efficiency. Consistent with this idea, only cysteine
and histidine amino acid residues are used for catalysis in
many cysteine proteases, with other amino acids serving to increase
enzyme efficiency by stabilizing the active-site conformation
(
9).
In summary, we identified amino acid residues important for
Mac IgG endopeptidase activity, thereby providing new insight
into structure-activity relationships in this important virulence
protein. Together with our previous site-specific mutagenesis
results for Cys94 (
7), the data suggest that Cys94 and His262
are active-site residues, and Asp284 and Asp286 are important
for the enzymatic activity or structure of Mac. As shown for
streptococcal pyrogenic exotoxin B, another extracellular cysteine
protease made by GAS (
4), crystal structure analysis will be
important to resolve the relationships of the amino acid residues
in and around the active site and to define the catalytic and
structural roles of these residues. The Mac mutants described
herein will facilitate further study of the mechanism used by
Mac to inhibit opsonophagocytosis and killing of GAS by human
PMN (
6,
7).

FOOTNOTES
* Corresponding author. Mailing address: Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 S. 4th St., Hamilton, MT 59840. Phone: (406) 363-9315. Fax: (406) 363-9427. E-mail:
jmusser{at}niaid.nih.gov.

Editor: D. L. Burns

REFERENCES
1 - Barrett, A. J., and N. D. Rawlings. 2001. Evolutionary lines of cysteine peptidase. Biol. Chem. 382:727-733.[CrossRef][Medline]
2 - Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.[Abstract/Free Full Text]
3 - Frank, M. M. 2001. Annihilating host defense. Nat. Med. 7:1285-1286.[CrossRef][Medline]
4 - Kagawa, T. F., J. C. Cooney, H. M. Baker, S. McSweeney, M. Liu, S. Gubba, J. M. Musser, and E. N. Baker. 2000. Crystal structure of the zymogen form of the streptococcal virulence factor SpeB: an integrin-binding cysteine protease. Proc. Natl. Acad. Sci. USA 97:2235-2240.[Abstract/Free Full Text]
5 - Lei, B., S. Mackie, S. Lukomski, and J. M. Musser. 2000. Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect. Immun. 68:6807-6818.[Abstract/Free Full Text]
6 - Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homologue of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.[CrossRef][Medline]
7 - Lei, B., F. R. DeLeo, S. D. Reid, J. M. Voyich, L. Magoun, M. Liu, K. R. Braughton, S. Ricklefs, N. P. Hoe, R. L. Cole, J. M. Leong, and J. M. Musser. 2002. Opsonophagocytosis-inhibiting Mac protein of group A Streptococcus: identification and characteristics of two genetic complexes. Infect. Immun. 70:6880-6890.[Abstract/Free Full Text]
8 - Lewis, S. D., F. A. Johnson, and J. A. Shafer. 1981. Effect of cysteine-25 on the ionization of histidine-159 in papain as determined by proton nuclear magnetic resonance spectroscopy: evidence for a His-159-Cys-25 ion pair and its possible role in catalysis. Biochemistry 20:48-51.[CrossRef][Medline]
9 - Vernet, T., D. C. Tessier, J. Chatellier, C. Plouffe, T. S. Lee, D. Y. Thomas, A. C. Storer, and R. Menard. 1995. Structural and functional roles of asparagine 175 in the cysteine protease papain. J. Biol. Chem. 270:16645-16652.[Abstract/Free Full Text]
10 - von Pawel-Rammingen, U., B. P. Johansson, and L. Björck. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21:1607-1615.[CrossRef][Medline]
Infection and Immunity, May 2003, p. 2881-2884, Vol. 71, No. 5
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.5.2881-2884.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wenig, K., Chatwell, L., von Pawel-Rammingen, U., Bjorck, L., Huber, R., Sondermann, P.
(2004). Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc. Natl. Acad. Sci. USA
101: 17371-17376
[Abstract]
[Full Text]
-
Agniswamy, J., Lei, B., Musser, J. M., Sun, P. D.
(2004). Insight of Host Immune Evasion Mediated by Two Variants of Group A Streptococcus Mac Protein. J. Biol. Chem.
279: 52789-52796
[Abstract]
[Full Text]